“Stratipath Breast is the first solution of its kind in the world that can provide prognostic information, predicting outcomes for breast cancer patients. Previous technologies were based on gene expression, but few patients had access to those analysis methods. With AI, you can achieve much greater accessibility and faster results.” / Johan Hartman, MedTech magazine.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. More information about our Cookie Policy and Privacy policy.